Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral prednisone vs. intratympanic methylprednisolone in SSNHL
NCT00097448Phase 3Completed
- Sponsor
- Massachusetts Eye and Ear
- Start
- Dec 2004
- Primary completion
- Oct 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone sodium succinate in sudden sensorineural hearing loss (SSHL), sponsored by Massachusetts Eye and Ear. Started Dec 2004; status: completed.
02
Drugs
methylprednisolone sodium succinate
03
Conditions
sudden sensorineural hearing loss (SSHL)
Beyond the preview
Go deeper on NCT00097448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00097448.